Back to 
BlackRock, Inc.
BlackRock, Inc.
RNA2 quarters
Position history for BlackRock, Inc.'s holdings in ATRIUM THERAPEUTICS INC
BlackRock, Inc. holds 1.4M shares of RNA (ATRIUM THERAPEUTICS INC), worth $19.5M as of 2026-Q2. The position was increased (+20.1% shares). RNA represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$19.5M
Current Shares
1.4M
Total Value Change
+$3.4M
Total Shares Change
+242,185
Quarter-by-Quarter History
Other major holders of RNA: PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC, Pentwater Capital Management LP